Pro-Zenix Pharmaceuticals Private Limited - Company Profile

It is a construction private limited company based in New Delhi, Delhi, India, established in 2007.
2007 New Delhi, Delhi, India Struck Off
Last Updated:
About Pro-Zenix Pharmaceuticals Private Limited

Pro-Zenix Pharmaceuticals Private Limited, a struck off private limited company, was established on 03 July 2007 in New Delhi, Delhi, India. Engaging in building construction within the construction sector, it holds CIN: U45400DL2007PTC165473. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.10 M.

Its leadership includes Anurag Bisht (Director), Yashwant Singh Bist (Director). Its latest AGM occurred on 30 September 2013, with the balance sheet filed on 31 March 2013. It is based at M-161/1 G.L. House, Commercial Complex, Yusuf Sarai, New Delhi, Delhi, 110049.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U45400DL2007PTC165473

  • Registration Number

    165473

  • Incorporation Date

    03 July 2007

  • Authorized Capital

    ₹0.20 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.20 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 18 Year, 7 Months
  • Last Filing with ROC 31 Mar 2013
Company report

Pro-Zenix Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Pro-Zenix Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Pro-Zenix Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Anurag Bisht Director 03 Jul 2007 Current
Yashwant Singh Bist Director 03 Jul 2007 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Pro-Zenix Pharmaceuticals.

Enhance accessibility to Pro-Zenix Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Pro-Zenix Pharmaceuticals revenue growth over time
Pro-Zenix Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Pro-Zenix Pharmaceuticals?

Unlock access to Pro-Zenix Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Pro-Zenix Pharmaceuticals?

Unlock and access historical data on people associated with Pro-Zenix Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Pro-Zenix Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pro-Zenix Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Pro-Zenix Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Pro-Zenix Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2013 as per latest MCA records. was completed.

  • Balance Sheet

    Pro-Zenix Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2013 with Roc Delhi. was recorded as a recent event.

  • Director Appointment

    Anurag Bisht was appointed as a Director was appointed as a Director on 03 Jul 2007 & has been associated with this company since 18 years 7 months . was recorded as a recent event.

  • Director Appointment

    The activity Yashwant Singh Bist was appointed as a Director was appointed as a Director on 03 Jul 2007 & has been associated with this company since 18 years 7 months . was completed.

  • Company Incorporation

    Pro-Zenix Pharmaceuticals Private Limited was registered on 03 Jul 2007 with Roc Delhi & aged 18 years 7 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Pro-Zenix Pharmaceuticals Private Limited?

The CIN of Pro-Zenix Pharmaceuticals Private Limited is U45400DL2007PTC165473.

Where is Pro-Zenix Pharmaceuticals Private Limited headquartered?

Pro-Zenix Pharmaceuticals Private Limited is headquartered at M-161/1 G.L. House, Commercial Complex, Yusuf Sarai, New Delhi, Delhi, 110049.

When was Pro-Zenix Pharmaceuticals Private Limited incorporated?

Pro-Zenix Pharmaceuticals Private Limited was incorporated on 03 July 2007.

Who are the current directors of Pro-Zenix Pharmaceuticals Private Limited?

The current directors of Pro-Zenix Pharmaceuticals Private Limited are

What is the primary industry of Pro-Zenix Pharmaceuticals Private Limited?

The primary industry of Pro-Zenix Pharmaceuticals Private Limited is Construction.

Is Pro-Zenix Pharmaceuticals Private Limited a listed company?

Pro-Zenix Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Pro-Zenix Pharmaceuticals Private Limited?

The authorized capital of Pro-Zenix Pharmaceuticals Private Limited is ₹0.20 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available